Without Pfizer appeal, Daiichi Sankyo closes long-running ADC patent arbitration with $47M win

Without Pfizer appeal, Daiichi Sankyo closes long-running ADC patent arbitration with $47M win aliu Fri, 06/28/2024 - 10:22